F-group (family)
331.3.1.3 START
Ligands and drugs
406
Member domains
51
with ligand contacts (≤ 4 Å)
12.6% of members
45
with DrugDomain annotations
11.1% of members
19
with a DrugBank compound
4.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 331.3.1.3 belongs to X-group 331 TBP-like, which binds 9.3 ligand superclasses per 20 proteins, broader than 85% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04372 | DLP | L-Dilinoleoyllecithin | 3 |
| DB02306 | CPL | Palmitoyl-Linoleoyl Phosphatidylcholine | 2 |
| DB01694 | TAR | D-tartaric acid | 1 |
| DB08231 | MYR | Myristic acid | 1 |
| DB09459 | TLA | L-tartaric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 16C | N-((E,2S,3R)-1,3-DIHYDROXYOCTADEC-4-EN-2-YL)PALMITAMIDE | 3 |
| 18C | N-((E,2S,3R)-1,3-DIHYDROXYOCTADEC-4-EN-2-YL)STEARAMIDE | 3 |
| DLP | 1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 3 |
| 14H | N-[(1R,3R)-3-hydroxy-1-(hydroxymethyl)-3-phenylpropyl]tetradecanamide | 2 |
| 16H | N-[(1R,3R)-3-hydroxy-1-(hydroxymethyl)-3-phenylpropyl]hexadecanamide | 2 |
| 9MC | 2-[4-[4-cyclopentyl-3-[(1~{S},2~{R})-2-pyridin-2-ylcyclopropyl]phenyl]phenyl]sulfonylethanol | 2 |
| 9ML | 2-[4-[4-pentyl-3-[(1~{S},2~{R})-2-pyridin-2-ylcyclopropyl]phenyl]phenyl]sulfonylethanol | 2 |
| CLR | CHOLESTEROL | 2 |
| CPL | 1-PALMITOYL-2-LINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 2 |
| DDR | (2S)-3-hydroxypropane-1,2-diyl didecanoate | 2 |
| H13 | N-[(1R,3R)-3-hydroxy-1-(hydroxymethyl)-3-phenylpropyl]tridecanamide | 2 |
| H15 | N-[(1R,3R)-3-hydroxy-1-(hydroxymethyl)-3-phenylpropyl]pentadecanamide | 2 |
| MNmetal | MANGANESE (II) ION | 2 |
| 6CM | N-((E,2S,3R)-1,3-DIHYDROXYOCTADEC-4-EN-2-YL)HEXANAMIDE | 1 |
| 9M6 | 2-[4-[4-cyclopentyl-3-[(1~{R},2~{S})-2-pyridin-2-ylcyclopropyl]phenyl]phenyl]sulfonylethanol | 1 |
| 9N0 | 2-[4-[3-~{tert}-butyl-5-[(1~{R},2~{S})-2-pyridin-2-ylcyclopropyl]phenyl]phenyl]sulfonylethanol | 1 |
| 9N3 | 2-[4-[3-~{tert}-butyl-5-(2-pyridin-2-ylethyl)phenyl]phenyl]sulfonylethanol | 1 |
| A50 | 2-({4'-pentyl-3'-[2-(pyridin-2-yl)ethyl][1,1'-biphenyl]-4-yl}sulfonyl)ethan-1-ol | 1 |
| A59 | 2-({4'-pentyl-3'-[(Z)-2-(pyridin-2-yl)ethenyl][1,1'-biphenyl]-4-yl}sulfonyl)ethan-1-ol | 1 |
| B8X | 2-[4-[4-propyl-3-[(1~{S},2~{R})-2-pyridin-2-ylcyclopropyl]phenyl]phenyl]sulfonylethanol | 1 |